期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Role of artificial intelligence-based ocular biomarkers in hepatobiliary diseases:A scoping review
1
作者 Uday Pratap Singh Parmar Arvind Kumar Morya +2 位作者 Parul C Gupta atul arora Nipun Verma 《World Journal of Hepatology》 2025年第8期206-216,共11页
Artificial intelligence(AI)has become an indispensable tool in modern health care,offering transformative potential across clinical workflows and diagnostic innovations.This review explores the sation of AI technologi... Artificial intelligence(AI)has become an indispensable tool in modern health care,offering transformative potential across clinical workflows and diagnostic innovations.This review explores the sation of AI technologies in synthesizing and analyzing multimodal data to enhance efficiency and accuracy in health care delivery.Specifically,deep learning models have demonstrated remarkable capabilities in identifying seven categories of hepatobiliary disorders using ocular imaging datasets,including slit-lamp,retinal fundus,and optical coherence tomography images.Leveraging ResNet-101 neural networks,researchers have developed screening models and independent diagnostic tools,showcasing how AI can redefine diagnostic practices and improve accessibility,particularly in resource-limited settings.By examining advancements in AI-driven health care solutions,this article sheds light on both the challenges and opportunities that lie ahead in integrating such technologies into routine clinical practice. 展开更多
关键词 Artificial intelligence Ocular biomarkers Hepatobiliary disease Deep learning and Kayser-Fleischer ring
暂未订购
Intravitreal therapy for the management of diabetic retinopathy:A concise review
2
作者 atul arora Arvind K Morya +3 位作者 Parul C Gupta Nitin K Menia Prateek Nishant Vishali Gupta 《World Journal of Experimental Medicine》 2024年第4期104-119,共16页
Diabetic retinopathy(DR)is a serious microvascular complication of diabetes mellitus and may result in irreversible visual loss.Laser treatment has been the gold standard treatment for diabetic macular edema and proli... Diabetic retinopathy(DR)is a serious microvascular complication of diabetes mellitus and may result in irreversible visual loss.Laser treatment has been the gold standard treatment for diabetic macular edema and proliferative diabetic retinopathy for many years.Of late,intravitreal therapy has emerged as a cornerstone in the management of DR.Among the diverse pharmacotherapeutic options,anti-vascular endothelial growth factor agents have demonstrated remarkable efficacy by attenuating neovascularization and reducing macular edema,thus preserving visual acuity in DR patients. 展开更多
关键词 Diabetic retinopathy Intravitreal therapy Anti-vascular endothelial growth factor Macular edema Proliferative diabetic-retinopathy
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部